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IT is well established that tumour
xenografts, including tumours from
patients with primary cancer, can be
grown in thymectomized, irradiated mice
reconstituted with syngeneic bone marrow
cells (T-B+) (Castro, 1972; Franks, Per-
kins and Holmes, 1973; Cobb andMitchley,
1974). In all these studies, a method
similar to that of Miller et al. (1963) has
been used to produce the T-B+ mice,
although the technique proposed by
Miller and his colleagues formed the basis
for investigations unrelated to tumour
growth. Nevertheless, a high degree of
positive " takes " has been reported using
this method. It has also been observed
that some tumours regress immediately
after implantation whilst the same
tumours, in other T-B+ mice, continue to
grow. The reasons for this variation in
growth are not entirely clear. However,
it is possible that this may be due in part
to the fact that, following irradiation of
the mice at 900 rad, some 5%/o of viable
thymus-dependent (T) lymphocytes are
known to survive (Raff and Wortis,
1970). A further 5 o of T cells are
introduced with the syngeneic bone
marrow cell inoculum (Doenhoff and
Davies, 1971), making a residual pool of
some 10% T cells. Although the pro-
cedure used to produce the T-B+ mice is
standardized as far as possible, clearly
there is likely to be some variation
between individual mice and hetero-
geneity which may account for the differ-
ential growths of the tumours observed.
Perhapsofmoresignificanceisthe100%pool
of circulating T cells. In order to try and
eliminate the two possible sources con-
tributing to the pool, some mice in the
study were irradiated at 1200 rad and the
remainder at the standard 900 rad. In
addition, some mice from each group
received bone marrow cells previously
incubated with rabbit anti-mouse thymo-
cyte serum (ATS); the rest received
untreated bone marrow cells.
MATERIALS AND METHODS
Female CBA mice from the specific
pathogen-free colony at the National Insti-
tute for Medical Research, Mill Hill, London,
NW7 4RD were used in the study. They
were thymectomized at 4 weeks of age and
whole body irradiated with a lethal dose
(900 rad and 1200 rad) from a 60Co source 2
weeks later. Some mice from each irradia-
tion group were reconstituted with 107
syngeneic bone marrow cells which had been
previously incubated with 0 5 ml of ATS for
3 h at 37°C. The remaining mice received an
inoculum of 107 untreated syngeneic bone
marrow cells. Sixty mice were used in the
study.
The anti-thymocyte serum was prepared
by the method ofLevey and Medawar (1966).
Its efficacy in vivo was tested by the metlhod
of Stanbridge and Perkins (1969). TwvoGROWTH OF TUMOUR XENOGRAFTS IN MICE
tumour lines were studied. The HeLa cells
used were originally obtained from the
Central Public Health Laboratories, Colin-
dale, but were subsequently passaged in the
laboratory. They were shown to be free from
mycoplasma. Each mouse received 2 x 105
cells in a 0-2 ml inoculum by the subcuta-
neous route. The remaining mice received
pieces of solid tumour at least 9 mm3 from a
papillary cell carcinoma ofthe human bladder
on its fourth passage, also by the subcuta-
neous route. Histology confirmed the pre-
sence of a highly anaplastic tumour.
Growth of both implanted tumours was
assessed by measuring 2 axes at rightangles
using vernier callipers. The product of the
axes was designated the surface area of the
tumour.
RESULTS AND DISCUSSION
Figures 1 and 2 demonstrate the
growth patterns observed from the im-
planted HeLa and bladder tumours re-
spectively. Figure 1 shows that ATS
treatment of the bone marrow cells used
to reconsitute the mice irradiated at 900
rad enhanced the growth ofHeLatumours.
This enhancement persisted for more than
50 days after implantation (+ 50). By
Day + 63, the tumours implanted in the
900 rad mice showed sustained growth
whereas the tumours in the 900 rad +
ATS mice had regressed. A similar
enhanced growth pattern was observed in
the 1200 rad + ATS mice but by Day
+ 47 there was little difference in size
between these tumours and those in the
1200 rad mice. Unfortunately, the 1200
rad + ATS mice died at Day + 50. By
Day + 63, the 1200 rad mice showed a
rapid growth rate, which was maintained
to the end of the study. However, this
was always below the growth observed in
the 900 rad or 900 rad + ATS groups of
mice.
In Fig. 2, enhanced growth of the
implanted tumours was once again ob-
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FIu;. 1. The stIcutaneous growth ofHeLa tumours in T-B+ mice irradiated at 900 ra(l and 1200 rad, half of which were reconstituted with bone marrow cells pretrea.ted with ATS.
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FIa. 2.-The subcutaneous growth of a papillary cell carcinoma of the human bladder in T-B+ mice
irradiated at 900 rad and 1200 rad, half of which were reconstituted with bone marrow cells pre-
treated with ATS.
served in the 900 rad + ATS mice, when
compared with the 900 rad mice. Further-
more, unlike the HeLa tumours, this
enhancement of growth was maintained
to the end of the study period at Day
+ 70, and became more pronounced with
time. The tumours in the 1200 rad group
of mice were initially slow to grow but by
Day + 70 the growths observed were
exceeded only by the 900 rad + ATS
mice. In this study, the 1200 rad + ATS
mice died within a few days of implanta-
tion of the tumour.
From the results, it is clear that the
combination of irradiation and ATS in-
cubated bone marrow cells enhances
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subcutaneous growth of tumour xeno-
grafts derived from HeLa cell suspensions
and solid tumour implants. This suggests
that the 500 T cell population introduced
with the bone marrow cell inoculum may
be the significant factor controlling the
inhibition of implanted tumour growth.
In this study, it is not clear why the HeLa
tumours started to regress in the 900 rad
+ ATS mice at Day + 63. However,
Medawar (1969) has shown that ATS
treated mice do not recover full immuno-
logical competence until 50 days after the
end of ATS treatment. It is therefore
possible that the combination of a return
to immunological competence and the
relatively small tumour load present is
responsible for the gradual regression
observed. This did not occur in the
bladder tumour at 900 rad + ATS
because by Day + 63 the surface area of
the tumours was 4 times as great as in the
mice with the HeLa tumours, thus indi-
cating a well established graft. In the 900
rad mice, growth was slow in both
tumour groups. It is suggested this is due
to the presence of the small pool of
immunologically competent cells intro-
duced with the bone marrow cell inoculum,
against which the establishment oftumour
growth is achieved.
The comparatively slow growth rates
initially obtained at 1200 rad (with or
without ATS) may be due to subcuta-
neous damage following irradiation, thus
inhibiting nutrition of the implanted
tumours. Even after a recovery period,
high irradiation levels do not appear to be
superior to the lower levels of irradiation
used. The failure to produce surviving
1200 rad + ATS mice in the solid tumour
groups is thought to be due to the com-
bined effect of 1200 rad, ATS, and ether
anaesthesia. Ether anaesthesia was not
required when HeLa cells were injected.
In this particular study, there was no
observed variation in the inter-mouse
survival of tumours.
The combination of 900 rad + bone
marrow cells incubated with ATS en-
hanced growth ofimplanted tumours and,
in the case of solid tumours, sustained
enhanced growth in excess of 2200 at
Day + 70 when compared with the 900
rad mice. The use of bone marrow
incubated with ATS (rather than bone
marrow alone) is therefore considered to
be a worthwhile addition to the standard
technique for growing tumour xenografts.
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